Clinical trial
A Phase I Study of a Novel Tracer for Positron Emission Tomography "PET" Myocardial Perfusion Imaging "MPI"
NCT02720354 is registered in ClinicalTrials.gov with Synektik S.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Study of a Novel Tracer for Positron Emission Tomography "PET" Myocardial Perfusion Imaging "MPI"
- Lead sponsor
- Synektik S.A.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- May 31, 2016
- Completion date
- May 31, 2017
- Enrollment
- 12 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.